Research summary, narrative review, 2013

Occupational Risks of Chronic Low Dose Radiation Exposure in Cardiac Catheterisation Laboratory

2013

Open the source page

In plain language

This review estimates that interventional cardiologists accumulate 50-200 mSv over a career, a projected cancer risk near 1 in 100, with high head doses. It describes a planned Italian study of cath lab staff using biomarkers; no results yet.

At a glance

Type of study
Narrative review
Who was studied
Interventional cardiologists, Nurses, Radiologic technologists, Mixed lab staff
Where
Italy
Summary based on
a web page

What it found

  • Cumulative occupational doses for interventional cardiologists over a 30-year career are estimated at 50 to 200 mSv, with a projected lifetime attributable excess cancer risk of about 1 in 100.

    Key figures: 50 to 200 mSv; 1 in 100

  • Interventional cardiologists receive two to ten times the annual exposure of diagnostic radiologists.

    Key figures: two to ten times higher

  • The operator's left side is more exposed than the right, and less protected body parts such as the head and hands can receive 5 to 50 mSv per year.

    Key figures: 30% to 100%; 5 and 50 mSv per year

  • Annual head exposure for interventional cardiologists is cited at 20-30 mSv, and higher without a ceiling-suspended screen.

    Key figures: 20-30 mSv per year

  • The planned Healthy Cath Lab case-control study will enrol 500 highly exposed cath lab staff (>3 years) and 500 matched unexposed controls, using a web survey and surrogate biomarkers.

    Key figures: 500 exposed, 500 controls

Limits to keep in mind

Narrative review and study-protocol rationale with no new data; risk figures are projections or drawn from cited studies, some observational and small, and the planned case-control study had not reported results.

How this summary was made

ORSIF prepared this summary with AI assistance from a web page of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.